NCT06679101
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06679101
Title A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM) (DREAMM-10)
Acronym DREAMM-10
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | POL | ITA | IRL | GRC | GBR | FRA | ESP | DEU | CZE | BEL | AUS | ARG

Facility Status City State Zip Country Details
GSK Investigational Site RECRUITING Mobile Alabama 36607 United States Details
GSK Investigational Site RECRUITING Kingwood Texas 77339 United States Details
GSK Investigational Site RECRUITING Capital Federal C1426ANZ Argentina Details
GSK Investigational Site RECRUITING Ciudad Autonoma de Buenos Aire 1414 Argentina Details
GSK Investigational Site RECRUITING Córdoba Argentina Details
GSK Investigational Site RECRUITING Rosario S2002 Argentina Details
GSK Investigational Site RECRUITING Viedma R8500ACE Argentina Details
GSK Investigational Site RECRUITING Gosford NSW New South Wales 2250 Australia Details
GSK Investigational Site RECRUITING Box Hill Victoria 3128 Australia Details
GSK Investigational Site RECRUITING Fitzroy Australia Details
GSK Investigational Site RECRUITING Bruges 8000 Belgium Details
GSK Investigational Site RECRUITING Brussels 1200 Belgium Details
GSK Investigational Site RECRUITING Ghent 9000 Belgium Details
GSK Investigational Site RECRUITING Hornu 7301 Belgium Details
GSK Investigational Site RECRUITING Roeselare 8800 Belgium Details
GSK Investigational Site RECRUITING Beijing 100191 China Details
GSK Investigational Site RECRUITING Guangzhou 510515 China Details
GSK Investigational Site RECRUITING Nanchang 330000 China Details
GSK Investigational Site RECRUITING Nanchang China Details
GSK Investigational Site RECRUITING Nanjing 210008 China Details
GSK Investigational Site RECRUITING Shanghia 200080 China Details
GSK Investigational Site RECRUITING Shenzhen 518039 China Details
GSK Investigational Site RECRUITING Tianjin 300020 China Details
GSK Investigational Site RECRUITING Wenzhou 325000 China Details
GSK Investigational Site RECRUITING Ostrava 708 52 Czechia Details
GSK Investigational Site RECRUITING Bobigny 93009 France Details
GSK Investigational Site RECRUITING Nantes 44202 France Details
GSK Investigational Site RECRUITING Villejuif 94805 France Details
GSK Investigational Site RECRUITING Dresden 01307 Germany Details
GSK Investigational Site RECRUITING Alexandroupoli 68 100 Greece Details
GSK Investigational Site RECRUITING Athens 106 76 Greece Details
GSK Investigational Site RECRUITING Athens 115 28 Greece Details
GSK Investigational Site RECRUITING Athens Greece Details
GSK Investigational Site RECRUITING Pátrai 26504 Greece Details
GSK Investigational Site RECRUITING Thessaloniki 54007 Greece Details
GSK Investigational Site RECRUITING Dublin D09V2N0 Ireland Details
GSK Investigational Site RECRUITING Waterford Ireland Details
GSK Investigational Site RECRUITING Ancona Italy Details
GSK Investigational Site RECRUITING Meldola FC 47014 Italy Details
GSK Investigational Site RECRUITING Roma 00161 Italy Details
GSK Investigational Site RECRUITING Aichi 467-8602 Japan Details
GSK Investigational Site RECRUITING Ehime 790-0024 Japan Details
GSK Investigational Site RECRUITING Ehime 790-8524 Japan Details
GSK Investigational Site RECRUITING Fukuoka 815-8555 Japan Details
GSK Investigational Site RECRUITING Fukushima 960-1295 Japan Details
GSK Investigational Site RECRUITING Gunma 371-8511 Japan Details
GSK Investigational Site RECRUITING Hyōgo 660-8550 Japan Details
GSK Investigational Site RECRUITING Hyōgo 670-8540 Japan Details
GSK Investigational Site RECRUITING Ibaraki 300-0028 Japan Details
GSK Investigational Site RECRUITING Ishikawa 920-8641 Japan Details
GSK Investigational Site RECRUITING Kanagawa 211-8510 Japan Details
GSK Investigational Site RECRUITING Miyagi 983-8520 Japan Details
GSK Investigational Site RECRUITING Nara 632-8552 Japan Details
GSK Investigational Site RECRUITING Numakunai 028-3695 Japan Details
GSK Investigational Site RECRUITING Sapporo 003-0006 Japan Details
GSK Investigational Site RECRUITING Suita 565-0871 Japan Details
GSK Investigational Site RECRUITING Tokyo 105-8471 Japan Details
GSK Investigational Site RECRUITING Yamagata 990-9585 Japan Details
GSK Investigational Site RECRUITING Lublin Poland Details
GSK Investigational Site RECRUITING Hwasun 519-763 South Korea Details
GSK Investigational Site RECRUITING Jeonju 561-712 South Korea Details
GSK Investigational Site RECRUITING Seoul 03080 South Korea Details
GSK Investigational Site RECRUITING Seoul 03722 South Korea Details
GSK Investigational Site RECRUITING Seoul 06351 South Korea Details
GSK Investigational Site RECRUITING Seoul 06591 South Korea Details
GSK Investigational Site RECRUITING Seoul 138-736 South Korea Details
GSK Investigational Site RECRUITING Ulsan 44033 South Korea Details
GSK Investigational Site RECRUITING Badalona Spain Details
GSK Investigational Site RECRUITING Barcelona 08035 Spain Details
GSK Investigational Site RECRUITING Gijón 33394 Spain Details
GSK Investigational Site RECRUITING Madrid 28007 Spain Details
GSK Investigational Site RECRUITING Madrid 28041 Spain Details
GSK Investigational Site RECRUITING Madrid Spain Details
GSK Investigational Site RECRUITING Málaga 29010 Spain Details
GSK Investigational Site RECRUITING Murcia 30120 Spain Details
GSK Investigational Site RECRUITING Salamanca Spain Details
GSK Investigational Site RECRUITING Santander 39011 Spain Details
GSK Investigational Site RECRUITING Valladolid 47003 Spain Details
GSK Investigational Site RECRUITING Kaohsiung City 807 Taiwan Details
GSK Investigational Site RECRUITING Taipei 10002 Taiwan Details
GSK Investigational Site RECRUITING Plymouth PL6 8DH United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field